Newsroom
Newsroom
Industry News
Back in 2015, a 40-year-old synthetic biologist named Christina Smolke, along with a small team of researchers at Stanford, made a huge discovery. They proved...
Industry News
In the current age of life sciences, we have come to invent better and better drugs that are increasingly efficient in relieving pain and treating...
Industry News
Obtaining compounds from nature, such as opioids from poppies or taxol from yew trees, is hard and time-consuming. So researchers, including Stanford's Christina Smolke, PhD,...
Industry News
The objective of this Phase I SBIR project will be to develop engineered yeast strains that produce high levels of noroxymorphone, the direct precursor for...
Industry News
The objectives of this Phase I project will be to develop engineered yeast strains that produce high levels of natural and non-natural noscapinoids secoberberines and...
Industry News
Until now, much of the medicines we use to treat dire illnesses have been derived from plants. But that means we are dependent on natural...